Moreover, we then discovered that the activation of CaMKII and mTOR, which increase synaptic damage and tau phosphorylation, respectively, was significantly enhanced in the mouse models of T2DM and AD, whereas the levels of p-CREB, the downstream protein of CaMKII, were markedly down-regulated. Here, CAMK2G is linked to Alzheimer disease.